Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,305 | 10,662 | 10,570 | 9,130 | 9,088 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,578 |
| Receivables | 67 | 1,559 | 40 | 3,706 | 41 |
| TOTAL | $25,184 | $14,266 | $11,150 | $13,744 | $10,904 |
| Non-Current Assets | |||||
| PPE Net | 177 | 224 | 318 | 257 | 242 |
| Other Non-Current Assets | 278 | 325 | 0 | 0 | 0 |
| TOTAL | $455 | $548 | $318 | $257 | $242 |
| Total Assets | $25,639 | $14,814 | $11,469 | $14,001 | $11,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,347 | 2,391 | 1,409 | 2,842 | 3,073 |
| Other current liabilities | 489 | 7,051 | 763 | 1,192 | N/A |
| TOTAL | $2,022 | $9,698 | $2,171 | $4,034 | $3,073 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,139 | 5,197 | 4,517 | 3,577 | 0 |
| TOTAL | $5,139 | $5,197 | $4,517 | $3,577 | $N/A |
| Total Liabilities | $7,161 | $14,896 | $6,689 | $7,611 | $3,073 |
| Shareholders' Equity | |||||
| Common Shares | 266,369 | 234,428 | 220,026 | 209,597 | 198,105 |
| Retained earnings | -274,049 | -259,695 | -240,309 | -227,136 | -210,572 |
| Other shareholders' equity | 2,999 | 3,076 | 3,260 | 3,079 | 419 |
| TOTAL | $18,478 | $-81 | $4,780 | $6,390 | $8,073 |
| Total Liabilities And Equity | $25,639 | $14,814 | $11,469 | $14,001 | $11,146 |